Evidence map›Paper›PMID 34663196›Full record

ArticleHealth marketing quarterly

Utilization of adequate provision in prescription drug broadcast ads among low- and non-Internet users.

Kevin R Betts, Kathryn J Aikin, Panne Burke, Stephanie Miles, Shane Mannis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health marketing quarterly. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kevin R BettsOffice of Prescription Drug Promotion, U.S. Food and Drug Administration, Silver Spring, MD, USA.
Kathryn J AikinOffice of Prescription Drug Promotion, U.S. Food and Drug Administration, Silver Spring, MD, USA.
Panne BurkeCommunication Research and Strategy, Fors Marsh Group, Arlington, VA, USA.
Stephanie MilesCommunication Research and Strategy, Fors Marsh Group, Arlington, VA, USA.
Shane MannisCommunication Research and Strategy, Fors Marsh Group, Arlington, VA, USA.

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

To fulfill a key regulation pertaining to prescription drug broadcast advertising, a common practice is to present the major risks along with "adequate provision" referencing several sources where audiences can obtain the full product labeling. In recent years, questions have arisen about the unique value of the various sources of adequate provision and even whether sponsor webpages alone may sufficiently convey product labeling information. Cognizant of the sizable offline population, the present research investigates questions of access, ability, likelihood, willingness, and preference among a nationally representative sample of low- and non-Internet users who may wish to access the product labeling.

Indexed as

Prescription DrugsAdvertisingHumansPrescription DrugsAdequate provisiondigital dividedirect-to-consumer prescription drug advertisingnon-internet usersoffline populationrisk communication

Identifiers

PMID34663196
PMCPMC9472712

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.